N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141651 |
| CAS No | NA |
| Mol.F. | C22H18ClN3O6 |
| Mol.Wt. | 455.85 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141652 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141653 |
| CAS No | NA |
| Mol.F. | C14H22N2O3 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141654 |
| CAS No | NA |
| Mol.F. | C8H18N2O5 |
| Mol.Wt. | 222.24g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141655 |
| CAS No | NA |
| Mol.F. | C14H22N2O2 |
| Mol.Wt. | 250.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141656 |
| CAS No | NA |
| Mol.F. | C11H14N2O3 |
| Mol.Wt. | 222.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141657 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141658 |
| CAS No | NA |
| Mol.F. | C14H21N3O3 |
| Mol.Wt. | 279.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141659 |
| CAS No | NA |
| Mol.F. | C15H23N3O4 |
| Mol.Wt. | 309.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141660 |
| CAS No | NA |
| Mol.F. | C8H14N2O2 |
| Mol.Wt. | 170.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141661 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141662 |
| CAS No | NA |
| Mol.F. | C11H16N2O2 |
| Mol.Wt. | 208.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141663 |
| CAS No | NA |
| Mol.F. | C26H23N9O3 |
| Mol.Wt. | 509.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141664 |
| CAS No | NA |
| Mol.F. | C21H14N8O4 |
| Mol.Wt. | 442.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141665 |
| CAS No | NA |
| Mol.F. | C23H24ClFN8O2 |
| Mol.Wt. | 498.95 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141666 |
| CAS No | NA |
| Mol.F. | C17H22ClN3O3 |
| Mol.Wt. | 351.8 |
| INV STATUS | CUSTOM SYNTHESIS |